Literature DB >> 6282411

Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.

G Williams, J D Sallis.   

Abstract

For a compound to inhibit potently the transformation of amorphous calcium phosphate into hydroxyapatite, it is suggested that the minimum structural requirement is a phosphate group and, at some other position, either another phosphate group preferably or a carboxylic moiety. Primary amino groups abolish inhibitor potential. Inhibitor potency is modified by various secondary factors, including the number and proximity of active groups, their stereochemistry, steric factors, the lability of the molecule, and in special instances its lipophilicity. Parameters used to monitor the transformation indicate that inhibitors can be grouped into two classes, and it is suggested that this is because one class acts as a hydroxyapatite crystal growth inhibitor. The close proximity of two phosphate groups or of a phosphate and multiple carboxylic groups is proposed to determine in part whether or not a compound acts as a crystal growth inhibitor. Further, bulky side groups render a molecule inactive as a crystal growth poison, although it will still inhibit by other mechanisms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282411     DOI: 10.1007/bf02411229

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  24 in total

1.  Effect of proteoglycans on in vitro hydroxyapatite formation.

Authors:  N C Blumenthal; A S Posner; L D Silverman; L C Rosenberg
Journal:  Calcif Tissue Int       Date:  1979-03-13       Impact factor: 4.333

2.  Theory of chromatography of rigid molecules on hydroxyapatite columns with small loads. I. The case when virtually all molecules are adsorbed on to a single type of crystal site through a single type of adsorption group.

Authors:  T Kawasaki
Journal:  J Chromatogr       Date:  1974-06-26

3.  The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals.

Authors:  A Jung; S Bisaz; H Fleisch
Journal:  Calcif Tissue Res       Date:  1973-03-30

4.  Calcium phosphate formation in vitro. II. Effects of environment on amorphous-crystalline transformation.

Authors:  J D Termine; R A Peckauskas; A S Posner
Journal:  Arch Biochem Biophys       Date:  1970-10       Impact factor: 4.013

5.  An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite.

Authors:  E D Eanes; J D Termine; M U Nylen
Journal:  Calcif Tissue Res       Date:  1973-05-09

6.  Comparative chemistry of amorphous and apatitic calcium phosphate preparations.

Authors:  J D Termine; E D Eanes
Journal:  Calcif Tissue Res       Date:  1972

7.  The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite.

Authors:  J L Meyer; G H Nancollas
Journal:  Calcif Tissue Res       Date:  1973-12-31

8.  Inositol phosphates and phytic acid as inhibitors of biological calcification in the rat.

Authors:  C J Van den Berg; L F Hill; S W Stanbury
Journal:  Clin Sci       Date:  1972-09       Impact factor: 6.124

9.  The effect of imidodiphosphate (P-N-P) on the precipitation and dissolution of calcium phosphate in vitro.

Authors:  W G Robertson; H Fleisch
Journal:  Biochim Biophys Acta       Date:  1970-12-29

10.  The growth of hydroxyapatite crystals.

Authors:  G H Nancollas; M S Mohan
Journal:  Arch Oral Biol       Date:  1970-08       Impact factor: 2.633

View more
  22 in total

1.  Inhibition of calcium phosphate precipitation by human salivary statherin: structure-activity relationships.

Authors:  S S Schwartz; D I Hay; S K Schluckebier
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

Review 2.  Environmental factors in the pathophysiology of recurrent idiopathic calcium urolithiasis (RCU), with emphasis on nutrition.

Authors:  P O Schwille; U Herrmann
Journal:  Urol Res       Date:  1992

Review 3.  Calcium orthophosphates: crystallization and dissolution.

Authors:  Lijun Wang; George H Nancollas
Journal:  Chem Rev       Date:  2008-09-25       Impact factor: 60.622

4.  Preparation and characterisation of calcium-phosphate porous microspheres with a uniform size for biomedical applications.

Authors:  C C Ribeiro; C C Barrias; M A Barbosa
Journal:  J Mater Sci Mater Med       Date:  2006-05       Impact factor: 3.896

5.  An Avrami analysis of the effects of serum and human albumin on calcium hydroxyapatite crystal growth.

Authors:  W M Mullins; C R Elsass
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

6.  Solubility of calcium salts, enamel, and hydroxyapatite in aqueous solutions of simple carbohydrates.

Authors:  K K Mäkinen; E Söderling
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

7.  Effectiveness of phosphocitrate and N-sulpho-2-amino tricarballylate, a new analogue of phosphocitrate, in blocking hydroxyapatite induced crystal growth and calcium accumulation by matrix vesicles.

Authors:  R Shankar; M R Brown; L K Wong; J D Sallis
Journal:  Experientia       Date:  1984-03-15

8.  Inhibition of hydroxyapatite formation by osteopontin phosphopeptides.

Authors:  David A Pampena; Karen A Robertson; Olga Litvinova; Gilles Lajoie; Harvey A Goldberg; Graeme K Hunter
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

9.  Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite.

Authors:  S M Qiu; G Wen; N Hirakawa; R D Soloway; N K Hong; R S Crowther
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  Adsorption and mineralization effects of citrate and phosphocitrate on hydroxyapatite.

Authors:  M Johnsson; C F Richardson; J D Sallis; G H Nancollas
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.